No recorded roll-call vote on this bill yet
Affordable Insulin Now Act
This bill limits cost-sharing for insulin under private health insurance.
Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2024.
Library of Congress summary, Mar 9, 2023
No amendments offered
No cost estimate or committee report yet
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 28, 2026.